Humana (NYSE: HUM) revenue
Humana reported revenue of $129,664m for fiscal 2025, 10.1% more than in fiscal 2024 ($117,761m). Since fiscal 2016 its revenue has grown by 138.4%, an average growth of 10.1% a year.
Revenue by fiscal year
| Fiscal year | Revenue | Change | Operating profit | Operating margin |
|---|---|---|---|---|
| 2025 | $129,664m | +10.1% | $2,704m | 2.1% |
| 2024 | $117,761m | +10.7% | $2,562m | 2.2% |
| 2023 | $106,374m | +14.5% | $4,013m | 3.8% |
| 2022 | $92,870m | +11.8% | $3,800m | 4.1% |
| 2021 | $83,064m | +7.7% | $3,148m | 3.8% |
| 2020 | $77,155m | +18.9% | $4,986m | 6.5% |
| 2019 | $64,888m | +14.0% | $3,192m | 4.9% |
| 2018 | $56,912m | +5.8% | $3,100m | 5.4% |
| 2017 | $53,767m | −1.1% | $4,262m | 7.9% |
| 2016 | $54,379m | — | $1,741m | 3.2% |
The change compares each fiscal year with the one before. Operating margin is operating profit over revenue from the same filing. Figures are in millions of US dollars, except per-share amounts.
Questions about the revenue of Humana
- How much revenue did Humana make in fiscal 2025?
- Humana reported revenue of $129,664m for fiscal 2025, compared with $117,761m in fiscal 2024.
- How much has the revenue of Humana grown?
- Between fiscal 2016 and fiscal 2025 it went from $54,379m to $129,664m: 138.4% more, an average growth of 10.1% a year.
- What was the best year for revenue at Humana?
- Of its last 10 fiscal years, fiscal 2025, with $129,664m.
- Where do the figures for Humana come from?
- From the annual report (Form 10-K) that Humana files with the SEC, the US securities regulator. Each fiscal year links to its filing.
Where each figure comes from
From the annual report (Form 10-K) that Humana files with the SEC. The filing for each fiscal year: 2025 · 2024 · 2023 · 2022 · 2021 · 2020 · 2019 · 2018 · 2017 · 2016. More on Humana: the Humana page · annual accounts · net income · dividends paid · insider transactions.
Dividend per share of Humana by fiscal year, with the filing behind every figure: Humana dividend history.
Information prepared from the accounts the company files with the regulator, for information purposes only. It is not financial advice or a recommendation to buy or sell. Updated on 12 November 2026.